Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis. (Q51529671)

6 April 2018

title

Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis. (English)

1 reference

6 April 2018

author

Bianca Weinstock-Guttman

6

object named as

Bianca Weinstock-Guttman

1 reference

6 April 2018

5

Murali Ramanathan

1 reference

6 April 2018

4

Robert Zivadinov

1 reference

6 April 2018

7

Atif B Awad

1 reference

6 April 2018

author name string

Michael Valerio

1

1 reference

6 April 2018

Hong-Biao Liu

2

1 reference

6 April 2018

Reid Heffner

3

1 reference

6 April 2018

publication date

7 December 2010

1 reference

6 April 2018

published in

Inflammation Research

1 reference

6 April 2018

volume

60

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

457-465

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s00011-010-0288-z

exact match

0 references

cites work

Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Multiple sclerosis: current pathophysiological concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

"Classic" myelin basic proteins are expressed in lymphoid tissue macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Pathogenesis of multiple sclerosis: an update on immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

The use of chemokine antagonists in EAE models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Phytosterols as anticancer compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Phytosterols in human nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Phytosterols and cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Oral absorption of phytosterols and emulsified phytosterols by Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Chronic Relapsing Experimental Allergic Encephalomyelitis in the SJL Mouse: Relevant Techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

beta-Sitosterol activates Fas signaling in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

beta-Sitosterol stimulates ceramide metabolism in differentiated Caco2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Statins in the treatment of central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

The study on the interaction between phytosterols and phospholipids in model membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0288-Z

A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies

21 January 2018

1 reference

12 December 2020

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

1 reference

12 December 2020

Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells

1 reference

12 December 2020

COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression

1 reference

12 December 2020

Effect of sesame oil on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice.

1 reference

12 December 2020

G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system

1 reference

12 December 2020

E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking

1 reference

12 December 2020

Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation

1 reference

12 December 2020

10.1007/S00011-010-0288-Z

Identifiers

DOI

1 reference

6 April 2018

release_ugqqqcwjozgl7nlgla6ug3ga5e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugqqqcwjozgl7nlgla6ug3ga5e

24 November 2022

mapped directly with Wikidata item

PubMed ID

21136279

1 reference

6 April 2018